Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ: MDGL · Real-Time Price · USD
302.17
-0.34 (-0.11%)
At close: Aug 1, 2025, 4:00 PM
300.00
-2.17 (-0.72%)
After-hours: Aug 1, 2025, 7:28 PM EDT

Accolade Stock Forecast

Stock Price Forecast

The 8 analysts that cover Accolade stock have a consensus rating of "Strong Buy" and an average price target of $420.63, which forecasts a 39.20% increase in the stock price over the next year. The lowest target is $350 and the highest is $469.

Price Target: $420.63 (+39.20%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$350$420.63$443$469
Change+15.83%+39.20%+46.61%+55.21%
* Price targets were last updated on May 2, 2025.

Analyst Ratings

The average analyst rating for Accolade stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy553555
Buy664443
Hold222111
Sell110000
Strong Sell000000
Total1414910109

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
UBS
UBS
Strong Buy
Maintains
$441$458
Strong BuyMaintains$441$458+51.57%May 2, 2025
B. Riley Securities
B. Riley Securities
Strong Buy
Reiterates
$422$460
Strong BuyReiterates$422$460+52.23%May 2, 2025
Canaccord Genuity
Canaccord Genuity
Strong Buy
Maintains
$394$420
Strong BuyMaintains$394$420+38.99%May 2, 2025
JMP Securities
JMP Securities
Buy
Reiterates
$443
BuyReiterates$443+46.61%Apr 24, 2025
Citigroup
Citigroup
Strong Buy
Maintains
$378$469
Strong BuyMaintains$378$469+55.21%Feb 27, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
696.52M
from 180.13M
Increased by 286.67%
Revenue Next Year
1.17B
from 696.52M
Increased by 67.98%
EPS This Year
-13.54
from -21.90
EPS Next Year
0.65
from -13.54
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
----180.13M696.52M1.17B1.81B
Revenue Growth
-----286.67%67.98%54.70%
EPS
-13.09-14.63-17.23-19.99-21.90-13.540.6518.79
EPS Growth
-------2,801.25%
Forward PE
------466.6816.09
No. Analysts
-----181714
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High827.8M1.6B2.2B
Avg696.5M1.2B1.8B
Low587.5M862.7M1.2B

Revenue Growth

Revenue Growth20252026202720282029
High
359.5%
123.5%
88.0%
Avg
286.7%
68.0%
54.7%
Low
226.1%
23.9%
-1.0%

EPS Forecast

EPS20252026202720282029
High-7.1820.3136.67
Avg-13.540.6518.79
Low-19.54-12.23-1.95

EPS Growth

EPS Growth20252026202720282029
High--
5,562.8%
Avg--
2,801.2%
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.